Synendos Therapeutics Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Basel, Switzerland
Description - Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Tags - Central Nervous System CNS
Team
Founder Dr Andrea Chicca
Founder
Funding
Synendos Therapeutics raised CHF20,000,000 with Kurma Partners and Sunstone Life Science Ventures and BERNINA BioInvest, Schroder Adveq, High-Tech Gr, Lichtsteiner Foundation - 11/12/2020